Serum free light chain assay: diagnosis and follow-up of treatment response
β2 microglobulin and LDH: tumor burden
Bone marrow biopsy:
better prognosis = hyperdiploidy
worse prognosis = deletion of chromosome 17p13 (10%) and certain translocations
Skeletal survey: Plain radiographs to identify lytic bone lesions and pathological fractures; bone scan is not useful in diagnosing lytic lesions
C) DIAGNOSTIC CRITERIA OF MULTIPLE MYELOMA
International Myeloma working group Diagnostic criteria: ≥2 of –
1. Asymptomatic:
M-protein ≥ 3 gm/dl and/or
Bone-marrow plasma cells ≥ 10%
2. Symptomatic: + ≥1 of CRAB
Corrected Calcium ≥ 11.5 mg/dl
Renal failure (Creatinine > 2 mg/dl)
Anemia (Hb < 10 gm/dl)
Bone (multiple lytic lesions/osteopenic)
D) VARIANTS
1 bone lesion, normal bone marrow, normal uninvolved immunoglobulins: biopsy shows solitary plasmacytoma
Soft tissue mass (Upper respiratory tract, GI), No bone lesion, Normal bone marrow: Biopsy shows Extramedullary plasmacytoma
No CRAB: Asymptomatic/Smoldering multiple myeloma
Normal CBC and chemistries, Bone marrow ≤ 10% plasma cells, No lytic lesions, M component < 3 gm/dl, Normal uninvolved Immunoglobulins, Often normal UPEP: Monocloncal Gammopathy of Undetermined Significance (MGUS)